---
title: "Golimumab - Psoriasis With Arthropathy"
sidebar: mydoc_sidebar
permalink: db06674-mesh-d015535-1.html
toc: false 
---


Path ID: `DB06674_MESH_D015535_1`
{% include image.html url="images/db06674-mesh-d015535-1.png" file="db06674-mesh-d015535-1.png" alt="db06674-mesh-d015535-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C529000 | Golimumab | Drug |
| UniProt:P01375 | Tumor necrosis factor | Protein |
| REACT:R-HSA-75893 | TNF signaling | Pathway |
| GO:0006954 | Inflammatory response | BiologicalProcess |
| MESH:D015535 | Psoriasis with arthropathy | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Golimumab | DECREASES ACTIVITY OF | Tumor Necrosis Factor |
| Tumor Necrosis Factor | PARTICIPATES IN | Tnf Signaling |
| Tnf Signaling | POSITIVELY REGULATES | Inflammatory Response |
| Inflammatory Response | CAUSES | Psoriasis With Arthropathy |
|---------|-----------|---------|

Reference: 
  - [https://en.wikipedia.org/wiki/Psoriatic_arthritis](https://en.wikipedia.org/wiki/Psoriatic_arthritis)
  - [https://go.drugbank.com/drugs/DB06674](https://go.drugbank.com/drugs/DB06674)
